These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771 [Abstract] [Full Text] [Related]
3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related]
4. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR. Menopause; 2007 May; 14(4):630-8. PubMed ID: 17224854 [Abstract] [Full Text] [Related]
5. The association of androgenic sex steroids with serum lipid levels in postmenopausal women. Noyan V, Yucel A, Sagsoz N. Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164 [Abstract] [Full Text] [Related]
6. Serum sex hormones in premenopausal women with coronary heart disease. Mohamad MJ, Karayyem M, Mohammad MA, Al-Alami J, Al-Hader A. Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999 [Abstract] [Full Text] [Related]
7. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, Davies JS. Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605 [Abstract] [Full Text] [Related]
8. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A, Freiberg JJ, Nordestgaard BG. Circulation; 2008 Nov 11; 118(20):2047-56. PubMed ID: 18955664 [Abstract] [Full Text] [Related]
9. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML. Artery; 1983 Nov 11; 12(1):1-23. PubMed ID: 6431945 [Abstract] [Full Text] [Related]
10. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. N Engl J Med; 1991 Aug 08; 325(6):373-81. PubMed ID: 2062328 [Abstract] [Full Text] [Related]
11. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. Hurley BF, Seals DR, Hagberg JM, Goldberg AC, Ostrove SM, Holloszy JO, Wiest WG, Goldberg AP. JAMA; 1984 Jul 27; 252(4):507-13. PubMed ID: 6737643 [Abstract] [Full Text] [Related]
12. An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males. Dobrzycki S, Serwatka W, Nadlewski S, Korecki J, Jackowski R, Paruk J, Ladny JR, Hirnle T. J Med Invest; 2003 Aug 27; 50(3-4):162-9. PubMed ID: 13678385 [Abstract] [Full Text] [Related]
13. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Undén AL, Elofsson S, Brismar K. Clin Endocrinol (Oxf); 2005 Jul 27; 63(1):94-102. PubMed ID: 15963068 [Abstract] [Full Text] [Related]
14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N. Indian Heart J; 2003 Jul 27; 55(3):234-40. PubMed ID: 14560932 [Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy. Cubrilo-Turek M, Sertić J, Duraković Z. Acta Med Croatica; 2001 Jul 27; 55(4-5):161-7. PubMed ID: 12398019 [Abstract] [Full Text] [Related]
16. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease. Mansfield E, McPherson R, Koski KG. J Am Diet Assoc; 1999 Nov 27; 99(11):1373-9. PubMed ID: 10570674 [Abstract] [Full Text] [Related]
17. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M. Nutr Metab Cardiovasc Dis; 2008 Sep 27; 18(7):492-6. PubMed ID: 17962002 [Abstract] [Full Text] [Related]
18. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. El ayachi M, Mziwira M, Vincent S, Defoort C, Portugal H, Lairon D, Belahsen R. Eur J Clin Nutr; 2005 Dec 27; 59(12):1379-86. PubMed ID: 16118656 [Abstract] [Full Text] [Related]
19. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA. Climacteric; 2008 Dec 27; 11(6):509-17. PubMed ID: 18991078 [Abstract] [Full Text] [Related]
20. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population. Krittayaphong R, Chotinaiwatarakul C, Kangkagate C, Bhuripanyo K, Mahanonda N. J Med Assoc Thai; 2006 Nov 27; 89 Suppl 5():S1-7. PubMed ID: 17722296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]